These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22842595)

  • 1. Cross-talk between virus and host innate immunity in pediatric HIV-1 infection and disease progression.
    Freguja R; Gianesin K; Zanchetta M; De Rossi A
    New Microbiol; 2012 Jul; 35(3):249-57. PubMed ID: 22842595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of innate immunity genes influence disease progression in HIV-1-infected children.
    Freguja R; Gianesin K; Del Bianco P; Malacrida S; Rampon O; Zanchetta M; Giaquinto C; De Rossi A
    AIDS; 2012 Mar; 26(6):765-8. PubMed ID: 22269973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
    Gonzalez VD; Landay AL; Sandberg JK
    Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Soluble factors with inhibitory activity against type 1 Human Immunodeficiency Virus].
    Zapata W; Montoya CJ; Rugeles MT
    Biomedica; 2006 Sep; 26(3):451-66. PubMed ID: 17176009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunopathogenesis of HIV infection.
    Paranjape RS
    Indian J Med Res; 2005 Apr; 121(4):240-55. PubMed ID: 15817942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1, interferon and the interferon regulatory factor system: an interplay between induction, antiviral responses and viral evasion.
    Marsili G; Remoli AL; Sgarbanti M; Perrotti E; Fragale A; Battistini A
    Cytokine Growth Factor Rev; 2012; 23(4-5):255-70. PubMed ID: 22748237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A frequent functional toll-like receptor 7 polymorphism is associated with accelerated HIV-1 disease progression.
    Oh DY; Baumann K; Hamouda O; Eckert JK; Neumann K; Kücherer C; Bartmeyer B; Poggensee G; Oh N; Pruss A; Jessen H; Schumann RR
    AIDS; 2009 Jan; 23(3):297-307. PubMed ID: 19114863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenetic basis of HIV-1 infection, transmission and disease progression.
    Singh P; Kaur G; Sharma G; Mehra NK
    Vaccine; 2008 Jun; 26(24):2966-80. PubMed ID: 18321617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cells in HIV-1 infection: a double-edged sword.
    Funke J; Dürr R; Dietrich U; Koch J
    AIDS Rev; 2011; 13(2):67-76. PubMed ID: 21587340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?
    Agrati C; D'Offizi G; Gougeon ML; Malkovsky M; Sacchi A; Casetti R; Bordoni V; Cimini E; Martini F
    AIDS Rev; 2011; 13(1):3-12. PubMed ID: 21412385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate immune factors associated with HIV-1 transmission.
    Pollakis G; Stax MJ; Paxton WA
    Curr Opin HIV AIDS; 2011 Sep; 6(5):341-7. PubMed ID: 21825869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity: toll-like receptors and some more. A brief history, basic organization and relevance for the human newborn.
    Fleer A; Krediet TG
    Neonatology; 2007; 92(3):145-57. PubMed ID: 17476116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals.
    Kulkarni PS; Butera ST; Duerr AC
    AIDS Rev; 2003; 5(2):87-103. PubMed ID: 12876898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virus-host interactions in paediatric HIV-1 infection.
    De Rossi A
    Curr Opin HIV AIDS; 2007 Sep; 2(5):399-404. PubMed ID: 19372918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate immunity in the control of HIV/AIDS: recent advances and open questions.
    Ploquin MJ; Jacquelin B; Jochems SP; Barré-Sinoussi F; Müller-Trutwin MC
    AIDS; 2012 Jun; 26(10):1269-79. PubMed ID: 22472855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent resistance to HIV-1 infection in CD4 T cells from exposed uninfected Vietnamese individuals is mediated by entry and post-entry blocks.
    Sáez-Cirión A; Versmisse P; Truong LX; Chakrabarti LA; Carpentier W; Barré-Sinoussi F; Scott-Algara D; Pancino G
    Retrovirology; 2006 Nov; 3():81. PubMed ID: 17092330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal innate immunity as a determinant of HIV susceptibility.
    Iqbal SM; Kaul R
    Am J Reprod Immunol; 2008 Jan; 59(1):44-54. PubMed ID: 18154595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and immunological host factors associated with susceptibility to HIV-1 infection.
    Buchacz KA; Wilkinson DA; Krowka JF; Koup RA; Padian NS
    AIDS; 1998; 12 Suppl A():S87-94. PubMed ID: 9632989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of host genetic expression patterns in HIV-infected individuals with divergent disease progression.
    Salgado M; López-Romero P; Callejas S; López M; Labarga P; Dopazo A; Soriano V; Rodés B
    Virology; 2011 Mar; 411(1):103-12. PubMed ID: 21239032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.